Pancreatic cancer is one of the deadliest types of cancer. It is often called a “silent disease” because it can grow for a long time without clear symptoms.
By the time it is diagnosed, it has usually spread to other parts of the body. This makes treatment very difficult, and many patients have limited options.
Because of this, scientists around the world are working hard to find new ways to fight this disease. A new study from The Wistar Institute and ChristianaCare offers an exciting breakthrough.
The research was published in the Proceedings of the National Academy of Sciences and reveals how pancreatic cancer cells survive—and how that process might be stopped.
At the center of this discovery are mitochondria, small structures inside cells that produce energy. In healthy cells, mitochondria are strong and well-protected. But in pancreatic cancer cells, the mitochondria are damaged and missing an important protein called Mic60.
Without this protein, the mitochondria lose their structure and begin to leak. They release a substance called double-stranded RNA into the cell. This is unusual because this type of RNA is normally associated with viruses.
When the cell detects this RNA, it reacts as if it is under attack. It activates a defense system involving two molecules called TLR3 and TRAF6. These molecules trigger inflammation, which is usually meant to protect the body.
However, cancer cells use this response in a very different way. Instead of being harmed by the inflammation, they use it to grow. The inflammation creates signals that help the cancer survive and spread.
The researchers found that the cancer cells become highly dependent on this process. It becomes a “survival trick” that the cancer relies on. Without this inflammation, the cancer cells cannot continue to live.
To test this, scientists blocked the TLR3 and TRAF6 pathway. The results were striking. The cancer cells died, while normal cells were not affected in the same way. In animal studies, tumors stopped growing when this pathway was blocked.
This suggests that the pathway could be a powerful new target for treatment. Instead of attacking cancer directly, doctors may be able to cut off the support system that cancer cells depend on.
This discovery is especially important because pancreatic cancer has very few effective treatments. Many existing therapies do not work well, and the disease is often resistant to drugs. Finding a new weakness in the cancer could lead to better outcomes in the future.
However, the research is still in an early stage. The experiments were mainly done in the laboratory and in animals. More studies are needed to confirm whether the same results will be seen in human patients. Scientists also need to develop safe drugs that can target this pathway.
Another limitation is that cancer is complex. Not all tumors behave in the same way, and some may not depend on this pathway. This means that future treatments may need to be tailored to each patient.
Even so, the study provides a new way of thinking about cancer. It shows that cancer cells can depend on processes that are normally meant to protect the body. By understanding these processes, scientists can find new ways to fight the disease.
In conclusion, this research reveals a surprising weakness in pancreatic cancer. By blocking the inflammation pathway caused by damaged mitochondria, it may be possible to stop cancer growth. While more work is needed, this discovery offers hope for new and more effective treatments in the future.
If you care about cancer, please read studies that low-carb diet could increase overall cancer risk, and new way to increase the longevity of cancer survivors.
For more health information, please see recent studies about how to fight cancer with these anti-cancer superfoods, and results showing daily vitamin D3 supplementation may reduce cancer death risk.
Source: The Wistar Institute.
